
A new obesity biotech launches; Gilead plans to quickly advance once-yearly PrEP for HIV
Today, a brief rundown of news involving Harbour BioMed and Gilead Sciences, as well as updates from Geron, Biogen and Genmab that you may have missed. Harbour BioMed on Wednesday launched a new biotechnology company, Élancé Therapeutics, that will develop …